# Dexlansoprazole

NDC: 50090-7451
Generic name: Dexlansoprazole
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20221122

FDA application: ANDA202294

## Active ingredients

- DEXLANSOPRAZOLE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-7451"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-7451
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc3de800-bfad-4e2f-b664-d58a67550b2f